The latest closing stock price for Terns Pharmaceuticals as of June 18, 2025 is 4.00.
An investor who bought $1,000 worth of Terns Pharmaceuticals stock at the IPO in 2021 would have $-782 today, roughly -1 times their original investment - a -31.71% compound annual growth rate over 4 years.
The all-time high Terns Pharmaceuticals stock closing price was 27.25 on March 19, 2021.
The Terns Pharmaceuticals 52-week high stock price is 11.40, which is 185% above the current share price.
The Terns Pharmaceuticals 52-week low stock price is 1.86, which is 53.5% below the current share price.
The average Terns Pharmaceuticals stock price for the last 52 weeks is 5.68.
An investor who bought $1,000 worth of Terns Pharmaceuticals stock at the IPO in 2021 would have $-782 today, roughly -1 times their original investment - a -31.71% compound annual growth rate over 4 years.
The all-time high Terns Pharmaceuticals stock closing price was 27.25 on March 19, 2021.
The Terns Pharmaceuticals 52-week high stock price is 11.40, which is 185% above the current share price.
The Terns Pharmaceuticals 52-week low stock price is 1.86, which is 53.5% below the current share price.
The average Terns Pharmaceuticals stock price for the last 52 weeks is 5.68.